AAL-881

N/A

Report date: 2025/06/11 20:01:15

NME

Base Information

Drug NameAAL-881

Drug Alias NameAAL-881NVP-AAL881

ClassificationSmall molecules

Mechanisms of ActionAnticancer protein kinase inhibitorsRAF serine/threonine protein kinase inhibitorsVascular endothelial growth factor receptor antagonists

TargetsRAF serine/threonine protein kinaseVascular endothelial growth factor receptor

Therapy Area/IndicationsGlioma

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusPending (Preclinical)

Highest Status in ChinaN/A

Originator CompaniesNovartis Institutes For Biomedical Research Inc

China Registration ClassN/A

Develop Information

Active CompaniesN/A

Inactive CompaniesNovartis Institutes For Biomedical Research Inc

Active IndicationsN/A

Inactive IndicationsGlioma

Other Information

ATC CodeN/A